Brief: C4x Discovery Signs Exclusive Global Licence Worth Up To $402 Million With Astrazeneca

C4X Discovery Holdings

28/11/2022 07:42

Nov 28 (Reuters) - AstraZeneca PLC  AZN.L :
    * SIGNS EXCLUSIVE GLOBAL LICENCE WORTH UP TO $402 MILLION
WITH
ASTRAZENECA FOR DEVELOPMENT & COMMERCIALISATION OF NRF2
ACTIVATOR PROGRAMME
    * C4XD WILL RECEIVE PRE-CLINICAL MILESTONE PAYMENTS WORTH UP
TO
$16 MILLION AHEAD OF FIRST CLINICAL TRIAL
    * IN ADDITION, C4XD IS ELIGIBLE TO RECEIVE A FURTHER
POTENTIAL
$385.8 MILLION

Source text for Eikon:  ID:nGNX1wd6f2 
Further company coverage:  AZN.L 
 ((Reuters.Briefs@thomsonreuters.com;))